Sanofi ADR (SNY)
NASDAQ · Healthcare · Drug Manufacturers - General
Sanofi ADR is a Healthcare company with a market capitalization of $104.85B, a trailing P/E ratio of 23.4, and a dividend yield of 5.53%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025 · in EUR
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 23, 2026 | $1.10 | $1.03 | +6.8% |
| Q4 2025 | January 29, 2026 | $0.91 | $0.85 | +7.1% |
| Q3 2025 | October 24, 2025 | $1.69 | $1.57 | +7.6% |
| Q2 2025 | July 31, 2025 | $0.91 | $1.00 | -9.0% |
| Q1 2025 | April 24, 2025 | $1.02 | $0.95 | +7.4% |
| Q4 2024 | January 30, 2025 | $0.68 | $0.74 | -8.1% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 7,371,480 | — | 2.4 | +10.9% |
| June 30, 2026 | 6,646,490 | — | 1.2 | +3.4% |
| June 15, 2026 | 6,427,889 | — | 2.6 | -4.5% |
| May 29, 2026 | 6,729,800 | — | 2.8 | +3.4% |
| May 15, 2026 | 6,507,411 | — | 2.4 | -17.6% |
| April 30, 2026 | 7,896,235 | — | 2.9 | +3.4% |
| April 15, 2026 | 7,636,386 | — | 2.9 | +3.2% |
| March 31, 2026 | 7,398,344 | — | 2.2 | +0.9% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Sanofi ADR's market cap?
As of August 13, 2026, Sanofi ADR (SNY) has a market capitalization of $104.85B.
What is Sanofi ADR's P/E ratio?
Sanofi ADR trades at a trailing price-to-earnings (P/E) ratio of 23.4. Its forward P/E is 8.6.
Does Sanofi ADR pay a dividend?
Yes — Sanofi ADR pays a dividend yielding 5.53%, an annual payout of $4.12 per share.
What sector is SNY in?
Sanofi ADR is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Sanofi ADR's short interest?
As of the July 15, 2026 FINRA settlement, 7,371,480 SNY shares were sold short. Days to cover: 2.4. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Sanofi ADR's revenue?
In its latest reported fiscal year (ending December 31, 2025), Sanofi ADR reported revenue of 46.72B EUR and net income of 7.81B EUR.
Ask your own questions about SNY
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.